Discontinuation of PAR-11-343 "NeuroNEXT Clinical Trials (U01)"

Notice Number: NOT-NS-13-034

Update: The following update relating to this announcement has been issued:

  • July 16, 2013 - See Notice NOT-NS-13-036. Notice of Intent to Publish a Revised Funding Opportunity Announcement for NeuroNEXT Clinical Trials (U01).

Key Dates
Release Date: July 3, 2013

Related Announcements

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)


This Notice informs potential applicants that NINDS will discontinue PAR-11-343 "NeuroNEXT Clinical Trials (U01). Applications will not be accepted by NINDS for this Funding Opportunity Announcement after August 3, 2013.


Please direct all inquiries to:

D. Elizabeth McNeil, MD, MSc
National Institute of Neurological Disorders and Stroke
Office of Clinical Trials
6001 Executive Blvd, Room 2114
Bethesda, MD 20892
Telephone: (301) 496-4135
Email: mcneilde@ninds.nih.gov